Scopus BioPharma Inc. — Regulation A 1-A/A
Scopus BioPharma Inc. of NEW YORK, NY filed a Regulation A 1-A/A with the SEC on 2020-01-16. Aggregate offering: $1.0M (Tier 2). Industry: Other.
Offering
- Filed: 2020-01-16
- Form: 1-A/A
- Accession: 0001104659-20-004812
- Tier: Tier 2
- Total aggregate offering: $1.0M
- Issuer portion: $1.0M
- Price per security: $5.0000
- Securities offered: Equity (common or preferred stock), Option, warrant or other right to acquire another security, Security to be acquired upon exercise of option, warrant or other right to acquire security
- Audit status: Audited
- Auditor: Citrin Cooperman & Company, LLP
- Jurisdictions: 13 states/territories
Issuer
- CIK: 0001772028
- Organized in: DE
- Incorporated: 2017
- Address: 420 LEXINGTON AVENUE, SUITE 300, NEW YORK, NY, 10170
- Phone: 212-479-2513
- Employees: 2 full-time
Financial snapshot (as filed)
- Total assets: $1.5M
- Cash & equivalents: $869K
- Total liabilities: $379K
- Stockholder equity: $1.1M
- Net income: $-930K
People (2)
| Name | Role | Location |
|---|
| Mark Wishner | Signer | NEW YORK, NY |
| Joshua R. Lamstein | Chairman | NEW YORK, NY |
Other Reg A filings by this issuer (11)
More